Monthly ibandronate for the prevention of bone loss in patients after liver transplantation

Transplantation Proceedings

Volumn 44, Issue 5, 2012, Pages 1362-1367

  Kaemmerer, D ^a   Schmidt, B ^b   Lehmann, G ^b   Wolf, G ^b   Hommann, M ^a   Settmacher, U ^b  

^a ZENTRALKLINIK BAD BERKA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL; DEOXYPYRIDINOLINE; IBANDRONIC ACID; PYRIDINOLINE;

ADULT; ARTICLE; BONE DENSITY; FEMALE; FEMUR NECK; FRACTURE; HUMAN; LABORATORY TEST; LIVER TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEX DIFFERENCE;

ABSORPTIOMETRY, PHOTON; ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCIUM; CHI-SQUARE DISTRIBUTION; CHOLECALCIFEROL; CREATININE; DIETARY SUPPLEMENTS; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; FEMUR NECK; FRACTURES, BONE; GERMANY; HUMANS; LIVER TRANSPLANTATION; LUMBAR VERTEBRAE; OSTEOPOROSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861846231     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.01.133     Document Type: Article

References (36)

1. Cheung AM: Post-liver transplantation osteoporosis. J Hepatol 34:337, 2001
2. Compston JE: Osteoporosis after liver transplantation. Liver Transpl 9:321, 2003
3. Shah SH, Johnston TD, Jeon H, et al: Effect of chronic glucocorticoid therapy and the gender difference on bone mineral density in liver transplant patients. J Surg Res 135:238, 2006
4. Bia M: Evaluation and management of bone disease and fractures post transplant. Transplant Rev (Orlando) 22:52, 2008
5. Ninkovic M, Skingle SJ, Bearcroft PW, et al: Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 12:931, 2000
6. Abdelhadi M, Eriksson SA, Ljusk Eriksson S, et al: Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand J Gastroenterol 30:1210, 1995
7. Meys E, Fontanges E, Fourcade N, et al: Bone loss after orthotopic liver transplantation. Am J Med 97:445, 1994
8. Guichelaar MM, Schmoll J, Malinchoc M, et al: Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors. Hepatology 46:1198, 2007
9. Millonig G, Graziadei IW, Eichler D, et al: Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center center study. Liver Transpl 11:960, 2005
10. Eastell R, Dickson ER, Hodgson SF, et al: Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296, 1991
11. Leidig-Bruckner G, Hosch S, Dodidou P, et al: Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 357:342, 2001
12. Collier J: Bone disorders in chronic liver disease. Hepatology 46:1271, 2007
13. Shane E, Rodino MA, McMahon DJ, et al: Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. J Heart Lung Transplant 17:1089, 1998
14. Khan KM, Mulia S, Kaul R, et al: Effect of nutrition and body composition on bone density after liver transplantation. Transplant Proc 39:3292, 2007
15. Kasturi KS, Chennareddygari S, Mummadi RR: Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials. Transpl Int 23:200, 2010
16. Fahrleitner-Pammer A, Piswanger-Soelkner JC, Pieber TR, et al: Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized doubleblind, placebo-controlled trial. J Bone Miner Res 24:1335, 2009
17. Neuhaus R, Kubo A, Lohmann R, et al: Calcitriol in prevention and therapy of osteoporosis after liver transplantation. Transplant Proc 31:472, 1999
18. Bodingbauer M, Wekerle T, Pakrah B, et al: Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation. Am J Transplant 7:1763, 2007
19. Kaemmerer D, Lehmann G, Wolf G, et al: Treatment of osteoporosis after liver transplantation with ibandronate. Transpl Int 23:753, 2010
20. Monegal A, Navasa M, Guanabens N, et al: Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484, 2001
21. Reeves HL, Francis RM, Manas DM, et al: Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation. Liver Transpl Surg 4:404, 1998
22. Ringe JD, Dorst A, Faber H, et al: Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroidinduced osteoporosis: results from a long-term comparative study. Osteoporos Int 14:801, 2003
23. Crawford BA, Kam C, Pavlovic J, et al: Zoledronic acid prevents bone loss after liver transplantation: a randomized, doubleblind, placebo-controlled trial. Ann Intern Med 144:239, 2006
24. Lupo L, Panzera P, Tandoi F, et al: Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial. Transplantation 86:925, 2008
25. Spada M, Petz W, Bertani A, et al: Randomized trial of basiliximab induction versus steroid therapy in pediatric liver allograft recipients under tacrolimus immunosuppression. Am J Transplant 6:1913, 2006
26. Marubashi S, Dono K, Nagano H, et al: Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence. Clin Transplant 23:904, 2009
27. Foroncewicz B, Mucha K, Ryszkowska E, et al: Safety and efficacy of steroid-free immunosuppression with tacrolimus and daclizumab in liver transplant recipients: 6-year follow-up in a single center. Transplant Proc 41:3103, 2009
28. Pietrzyk M, Kruger B, Banas B, et al: Steroid-free organ transplantation. Lancet 363:737, 2004; author reply 737
29. Weiler N, Thrun I, Hoppe-Lotichius M, et al: Early steroidfree immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial. Transplantation
30. Leslie WD, Bernstein CN, Leboff MS: AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125:941, 2003
31. Kraenzlin ME, Kraenzlin CA, Meier C, et al: Automated HPLC assay for urinary collagen cross-links: effect of age, menopause, and metabolic bone diseases. Clin Chem 54:1546, 2008
32. Ringe JD, Dorst A, Faber H, et al: Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroidinduced osteoporosis. Rheumatology (Oxford) 42:743, 2003
33. Guichelaar MM, Kendall R, Malinchoc M, et al: Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 12:1390, 2006
34. Ebeling PR: Approach to the patient with transplantationrelated bone loss. J Clin Endocrinol Metab 94:1483, 2009
35. Cohen A, Sambrook P, Shane E: Management of bone loss after organ transplantation. J Bone Miner Res 19:1919, 2004
36. Ninkovic M, Love S, Tom BD, et al: Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J Hepatol 37:93, 2002